Most people around the world own a smartphone, including in emerging markets where smartphones already have more added value as they are also used for other needs due to a lack of infrastructure. One example here is banking, which has evolved from physical branches to mobile app based banking, credit cards and store cards. In some emerging markets mobile money has also taken off with mPOS (mobile Point of Sale) and mobile wallets (for example in India, China and Brazil).
As with the advances in banking, mobile phones are ready for the next steps in innovating health care, taking the business case beyond fitness and medical apps. Diagnostics and health monitoring are two future areas that would offer huge benefits to a health care constrained world as populations age and pandemics such as the yearly flu virus and recent Coronavirus (COVID-19) threaten to overwhelm hospitals and care facilities. Further, the economics cost of a pandemic such as the Coronavirus (COVID-19) could be enormous.
To this end LMD, the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, announces that its e-Checkup™ and V-Sensor technology is at an advanced stage of development and being trialled by phone companies in parallel with preparations for regulatory approval. The first medical device integrated into a smartphone that can measure five vital signs to medical accuracy, the company’s V-Sensor and e-Checkup app measures body temperature in around 10 seconds.